UBS Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Sell |
40,300
-10,700
| -21% | -$5.39M | ﹤0.01% | 2648 |
|
|
2025
Q4 | $23.8M | Buy |
51,000
+12,800
| +34% | +$5.94M | ﹤0.01% | 2415 |
|
|
2025
Q3 | $16.3M | Buy |
38,200
+10,000
| +35% | +$3.88M | ﹤0.01% | 2790 |
|
|
2025
Q2 | $10.8M | Sell |
28,200
-24,100
| -46% | -$8.68M | ﹤0.01% | 3007 |
|
|
2025
Q1 | $18.1M | Sell |
52,300
-87,000
| -62% | -$28M | ﹤0.01% | 2439 |
|
|
2024
Q4 | $41.8M | Sell |
139,300
-17,300
| -11% | -$6.05M | 0.01% | 1614 |
|
|
2024
Q3 | $63.6M | Buy |
156,600
+34,600
| +28% | +$12.7M | 0.01% | 999 |
|
|
2024
Q2 | $39.2M | Sell |
122,000
-49,700
| -29% | -$16.1M | 0.01% | 1201 |
|
|
2024
Q1 | $57.3M | Buy |
171,700
+81,100
| +90% | +$24.8M | 0.01% | 955 |
|
|
2023
Q4 | $24.5M | Buy |
90,600
+14,000
| +18% | +$3.46M | 0.01% | 1443 |
|
|
2023
Q3 | $18.8M | Buy |
76,600
+57,200
| +295% | +$15.7M | 0.01% | 1529 |
|
|
2023
Q2 | $5.89M | Sell |
19,400
-35,000
| -64% | -$9.73M | ﹤0.01% | 2426 |
|
|
2023
Q1 | $14.3M | Sell |
54,400
-32,000
| -37% | -$8.13M | 0.01% | 1641 |
|
|
2022
Q4 | $20.7M | Buy |
86,400
+22,600
| +35% | +$5.06M | 0.01% | 1388 |
|
|
2022
Q3 | $11.7M | Buy |
63,800
+59,800
| +1,495% | +$11.9M | 0.01% | 1658 |
|
|
2022
Q2 | $672K | Hold |
4,000
| – | – | ﹤0.01% | 4043 |
|
|
2022
Q1 | $1M | Sell |
4,000
-59,800
| -94% | -$15M | ﹤0.01% | 4096 |
|
|
2021
Q4 | $16.4M | Buy |
63,800
+61,800
| +3,090% | +$15.1M | ﹤0.01% | 1718 |
|
|
2021
Q3 | $485K | Buy |
+2,000
| New | +$489K | ﹤0.01% | 4757 |
|
|
2017
Q3 | – | Sell |
-600
| Closed | -$52K | – | 7837 |
|
|
2017
Q2 | $52K | Buy |
+600
| New | +$50.8K | ﹤0.01% | 5613 |
|
|
2017
Q1 | – | Sell |
-715,000
| Closed | -$52.9M | – | 7766 |
|
|
2016
Q4 | $52.9M | Hold |
715,000
| – | – | 0.03% | 522 |
|
|
2016
Q3 | $54.1M | Hold |
715,000
| – | – | 0.03% | 494 |
|
|
2016
Q2 | $55.1M | Sell |
715,000
-505,600
| -41% | -$39.9M | 0.03% | 470 |
|
|
2016
Q1 | $95.3M | Buy |
1,220,600
+1,220,100
| +244,020% | +$85.2M | 0.06% | 287 |
|
|
2015
Q4 | $34K | Hold |
500
| – | – | ﹤0.01% | 6208 |
|
|
2015
Q3 | $39K | Hold |
500
| – | – | ﹤0.01% | 6042 |
|
|
2015
Q2 | $45K | Sell |
500
-15,400
| -97% | -$1.23M | ﹤0.01% | 6085 |
|
|
2015
Q1 | $1.2M | Buy |
15,900
+13,200
| +489% | +$948K | ﹤0.01% | 3417 |
|
|
2014
Q4 | $198K | Buy |
+2,700
| New | +$190K | ﹤0.01% | 5055 |
|
Other funds holding HCA
VCM
VPM
UBS Group's HCA Position: Q1 2026 in Review
UBS Group reduced its HCA Healthcare (HCA) stake by 42% in Q1 2026, selling an estimated $233M and leaving 643,482 shares worth $305M. The position accounts for 0.05% of the portfolio, ranked #420.
UBS Group first reported a position in HCA in Q4 2014 and has held it in 46 quarters since. The position peaked at $683M in Q3 2025. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- UBS Group held 643,482 shares of HCA Healthcare worth $305M as of Q1 2026.
- UBS Group sold 462,294 HCA Healthcare shares in Q1 2026, an estimated $233M.
- HCA Healthcare made up 0.05% of UBS Group's portfolio in Q1 2026, its #420 holding.
- UBS Group first reported a position in HCA Healthcare in Q4 2014 and has held it in 46 quarters since.
- UBS Group's HCA Healthcare position peaked at $683M in Q3 2025.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.